secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK:        0001133869
Form:       8-K
Filed at:   2023-09-06T23:59:59+00:00
Accession:  0001558370-23-015482
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Capricor Therapeutics appoints Michael Kelliher to Board of Directors
---------------------------------------------------------------------

- Michael Kelliher appointed to Board effective September 1, 2023; Board size increased from 8 to 9.
- Kelliher is Group VP of M&A and Business Development at Horizon Therapeutics; 20+ years biotech/pharma experience.
- Receives initial nonstatutory stock option for 115,000 shares vesting over 3 years (25% at 1 year, then monthly).
- Will enter standard indemnification agreement; no committees assigned initially.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133869/000155837023015482/0001558370-23-015482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133869/000155837023015482/capr-20230901x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-015482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer